Cargando…

Continuous Influenza Virus Production in Cell Culture Shows a Periodic Accumulation of Defective Interfering Particles

Influenza viruses are a major public health burden during seasonal epidemics and a continuous threat due to their potential to cause pandemics. Annual vaccination provides the best protection against the contagious respiratory illness caused by influenza viruses. However, the current production capa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Frensing, Timo, Heldt, Frank Stefan, Pflugmacher, Antje, Behrendt, Ilona, Jordan, Ingo, Flockerzi, Dietrich, Genzel, Yvonne, Reichl, Udo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764112/ https://www.ncbi.nlm.nih.gov/pubmed/24039749 http://dx.doi.org/10.1371/journal.pone.0072288

Ejemplares similares

Multiscale Modeling of Influenza A Virus Infection Supports the Development of Direct-Acting Antivirals
por: Heldt, Frank S., et al.
Publicado: (2013)

A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome
por: Kupke, Sascha Young, et al.
Publicado: (2019)

Cell culture-based production of defective interfering particles for influenza antiviral therapy
por: Wasik, Milena A., et al.
Publicado: (2017)

Production of Modified Vaccinia Ankara Virus by Intensified Cell Cultures: A Comparison of Platform Technologies for Viral Vector Production
por: Gränicher, Gwendal, et al.
Publicado: (2020)

Single-cell analysis and stochastic modelling unveil large cell-to-cell variability in influenza A virus infection
por: Heldt, Frank S., et al.
Publicado: (2015)

Cell culture–based production of defective interfering influenza A virus particles in perfusion mode using an alternating tangential flow filtration system
por: Hein, Marc D., et al.
Publicado: (2021)

Production of Defective Interfering Particles of Influenza A Virus in Parallel Continuous Cultures at Two Residence Times—Insights From qPCR Measurements and Viral Dynamics Modeling
por: Tapia, Felipe, et al.
Publicado: (2019)

Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles
por: Hein, Marc D., et al.
Publicado: (2021)

Generation of “OP7 chimera” defective interfering influenza A particle preparations free of infectious virus that show antiviral efficacy in mice
por: Dogra, Tanya, et al.
Publicado: (2023)

Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems
por: Tapia, Felipe, et al.
Publicado: (2017)

Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy
por: Pelz, Lars, et al.
Publicado: (2021)

OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential
por: Hein, Marc D., et al.
Publicado: (2020)

Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara
por: Jordan, Ingo, et al.
Publicado: (2013)

High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2019)

High-cell-density cultivations to increase MVA virus production
por: Vázquez-Ramírez, Daniel, et al.
Publicado: (2018)

Performance of an acoustic settler versus a hollow fiber–based ATF technology for influenza virus production in perfusion
por: Gränicher, Gwendal, et al.
Publicado: (2020)

Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the “von Magnus effect”
por: Tapia, Felipe, et al.
Publicado: (2019)

Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells
por: Lohr, Verena, et al.
Publicado: (2012)

The avian cell line AGE1.CR.pIX characterized by metabolic flux analysis
por: Lohr, Verena, et al.
Publicado: (2014)

A system for production of defective interfering particles in the absence of infectious influenza A virus
por: Bdeir, Najat, et al.
Publicado: (2019)

Multiscale model of defective interfering particle replication for influenza A virus infection in animal cell culture
por: Rüdiger, Daniel, et al.
Publicado: (2021)

Flow cytometric monitoring of influenza A virus infection in MDCK cells during vaccine production
por: Schulze-Horsel, Josef, et al.
Publicado: (2008)

Cell-line screening and process development for a fusogenic oncolytic virus in small-scale suspension cultures
por: Göbel, Sven, et al.
Publicado: (2022)

Influenza virus intracellular replication dynamics, release kinetics, and particle morphology during propagation in MDCK cells
por: Frensing, Timo, et al.
Publicado: (2016)

Effect of influenza virus infection on key metabolic enzyme activities in MDCK cells
por: Janke, Robert, et al.
Publicado: (2011)

Large-scale networks in engineering and life sciences
por: Benner, Peter, et al.
Publicado: (2014)

Impact of different influenza cultivation conditions on HA N-Glycosylation
por: Roedig, Jana V, et al.
Publicado: (2011)

Bioreactors for high cell density and continuous multi-stage cultivations: options for process intensification in cell culture-based viral vaccine production
por: Tapia, Felipe, et al.
Publicado: (2016)

Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production
por: Nikolay, Alexander, et al.
Publicado: (2018)

MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation
por: Genzel, Yvonne, et al.
Publicado: (2010)

Impact of Influenza A Virus Infection on Growth and Metabolism of Suspension MDCK Cells Using a Dynamic Model
por: Ramos, João Rodrigues Correia, et al.
Publicado: (2022)

Metabolic effects of influenza virus infection in cultured animal cells: Intra- and extracellular metabolite profiling
por: Ritter, Joachim B, et al.
Publicado: (2010)

Impact of Host Cell Line Adaptation on Quasispecies Composition and Glycosylation of Influenza A Virus Hemagglutinin
por: Roedig, Jana Verena, et al.
Publicado: (2011)

Model-based analysis of influenza A virus replication in genetically engineered cell lines elucidates the impact of host cell factors on key kinetic parameters of virus growth
por: Laske, Tanja, et al.
Publicado: (2019)

Application of an Inclined Settler for Cell Culture-Based Influenza A Virus Production in Perfusion Mode
por: Coronel, Juliana, et al.
Publicado: (2020)

Site-specific N-glycosylation analysis of animal cell culture-derived Zika virus proteins
por: Pralow, Alexander, et al.
Publicado: (2021)

Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro
por: Pelz, Lars, et al.
Publicado: (2023)

High cell density perfusion process for high yield of influenza A virus production using MDCK suspension cells
por: Wu, Yixiao, et al.
Publicado: (2021)

Antiviral Activity of Influenza A Virus Defective Interfering Particles against SARS-CoV-2 Replication In Vitro through Stimulation of Innate Immunity
por: Rand, Ulfert, et al.
Publicado: (2021)

Single-Cell Analysis Uncovers a Vast Diversity in Intracellular Viral Defective Interfering RNA Content Affecting the Large Cell-to-Cell Heterogeneity in Influenza A Virus Replication
por: Kupke, Sascha Young, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j1b1ahma8n0ucar4qlvqlb7hr2